ANUHPHR
Start SIP
Invest Now
Start SIP in ANUHPHR
Performance
- Low
- ₹79
- High
- ₹82
- 52 Week Low
- ₹74
- 52 Week High
- ₹122
- Open Price₹82
- Previous Close₹81
- Volume12,632
Investment Returns
- Over 1 Month + 3.64%
- Over 3 Month -3.73%
- Over 6 Month -24.23%
- Over 1 Year -26.38%
Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!
Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.7
- PEG Ratio
- -0.6
- Market Cap Cr
- 800
- P/B Ratio
- 2.4
- Average True Range
- 2.47
- EPS
- 3.86
- Dividend Yield
- 1.9
- MACD Signal
- -0.81
- RSI
- 56.01
- MFI
- 54.12
Anuh Pharma Financials
Anuh Pharma Technicals
EMA & SMA
Current Price
₹79.82
-1.1
(-1.36%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹79.22
- 50 Day
- ₹81.00
- 100 Day
- ₹84.27
- 200 Day
- ₹88.46
Resistance and Support
80.98
- R3 83.70
- R2 82.81
- R1 81.87
- S1 80.04
- S2 79.15
- S3 78.21
Anuh Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-07 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2025-05-23 | Audited Results, Dividend & Bonus issue | |
| 2025-02-07 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2024-11-08 | Quarterly Results |
Anuh Pharma F&O
About Anuh Pharma
- NSE Symbol
- ANUHPHR
- BSE Symbol
- 506260
- Joint Managing Director
- Mr. Ritesh B Shah
- ISIN
- INE489G01022
Similar Stocks to Anuh Pharma
Anuh Pharma FAQs
Anuh Pharma share price is ₹79 As on 30 December, 2025 | 17:14
The Market Cap of Anuh Pharma is ₹800 Cr As on 30 December, 2025 | 17:14
The P/E ratio of Anuh Pharma is 20.7 As on 30 December, 2025 | 17:14
The PB ratio of Anuh Pharma is 2.4 As on 30 December, 2025 | 17:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.